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Parkinson´s disease affects the central nervous system 
resulting in voice quality alterations. It is typically resistant 
to drug therapy and often persists despite extensive 
behavioural speech and language therapy. Previous findings 
show that masking noise will produce a consistent increase 
in voice intensity in most normal individuals (Lombard’s 
effect). Aim: we evaluated Lombard’s effect’s implication in 
intensity, fundamental frequency and stability on the voice 
of individuals with Parkinson´s disease (N=17). Material 
and methods: through acoustic analysis, we evaluated 
intensity alterations and fundamental frequency, before and 
after white masking noise 40, 70 and 90 dBSL intensities, as 
well as variations during each vocalization and compared 
with a control group (N=16). Results: voice intensity varied 
according to masking intensity, tending to non-linear increases 
in both groups and gender. Fundamental frequency varied, 
tending to non-linear increase in both groups and gender. 
Improvement stability occurred in fundamental frequency 
and vocal intensity. Conclusion: Lombard’s effect increased 
intensity, fundamental frequency and improves voice stability 
on these patients. Study: clinical and experimental. 
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INTRODUCTION
Parkinson’s Disease (PD) was described in 1817 
by an English Physician called James Parkinson, publi-
shed with the title: “An assay on agitating paralysis”. It 
is a disease that affects the central nervous system, more 
specifically the neurons of the mesencephalic substantia 
nigra, responsible for releasing dopamine. A reduction in 
dopamine results in less inhibition of the basal nuclei’s 
activities, more precisely that of the corpus striatum, re-
sulting in muscle rigidity, bradykinesia, tremor at rest and 
postural disorders1.
As far as speech is concerned, these patients have: 
intensity reduction (this is the major and most marked 
vocal alteration, it is progressive as the disease evolves), 
vocal instability, monotones, qualitative alterations such 
as tremor, hoarseness and pitch alterations, difficulties to 
start a phrase, articulatory alterations, accelerated speech 
and words repetition in an unconscious and uncontrolled 
way. This set of alterations is called hypokinetic dysarthria 
or disartrophonia2-8.
As an alternative to reduce the complaints of hypo-
phonia in these patients, some authors have used auditory 
masking with the aim of improving voice intensity11,12. This 
method is known as the Lombard’s Effect, which makes 
it natural for the individual to speak louder, because of 
noise exposure, preventing him to hear it properly, or 
because of hearing loss9. The mechanisms involved in this 
phenomenon are yet to be established10.
Lombard’s Effect (LE) was studied, and there was a 
marked improvement in voice intensity of these patients 
when submitted to auditory masking at 90dB SPL (decibels 
sound pressure level)11. Other authors12 also studied the 
LE’s repercussion on the voice of patients with Parkinson’s, 
submitting them to auditory masking with 10 and 20 dBSL 
(decibels sensation level), and they did not obtain the same 
results achieved by Adams, Lang (1992)11.
The little information on this topic and the lack of 
agreement among the few papers available, about the 
method or the results attained, has triggered the interest 
for a study assessing the behavior of sound intensity and 
fundamental frequency, as well as voice utterance stabi-
lity in this group of patients when exposed to auditory 
masking.
Thus, this paper aimed at assessing, by means of 
an acoustic analysis, LE’s interference on the intensity and 
fundamental frequency in the voices of patients with PD, 
as well as the stability of each utterance.
MATERIALS AND METHODS
This study was approved by the Ethics Committee 
of our Institution, under protocol # 070/06.
Participants
We selected 33 participants: Patients with Parkinson’s 
(N=17,  8 men and 9 women) and the Control Group 
(N=16, 8 men and 8 women). All the participants freely 
signed the Informed Consent Form after being duly infor-
med about the procedures.
Inclusion Criteria for the Parkinson’s Group
1. Patients diagnosed with idiopathic Parkinson’s 
Disease (PD), without other associated neurological di-
sorders.
2. Audiometric threshold averages equal to or below 
20dB hearing level (dBHL) in the frequencies of 500, 1000 
and 2000 Hz, in both ears.
3. Have vocal quality between zero and one in the 
item: level of dysphonia, in the GRBAS scale13.
4. Have language impairment level between zero 
and one in the Webster scale14 of PD disability assess-
ment scale.
5. Have general impairment level between stages 
one and two in the Hoehn and Yahr’s scale15.
6. Use L-Dopa as drug treatment 
7. Age between 60 and 75 years.
Exclusion criteria for the Parkinson’s Group
We excluded those individuals who did not fit in 
items 1 to 7.
Control Group
We selected 16 individuals (8 women and 8 men) 
without auditory or vocal complaints, with ages varying 
between 60 and 75 years, who were later evaluated accor-
ding to items 2 and 3 as inclusion criteria for this group.
Procedures
Auditory evaluation
We carried out tonal audiometry in the frequencies 
of 500, 1,000 and 2,000Hz in both ears.
Perceptive vocal assessment
An assessment, according to the GRBAS and Webs-
ter scales, carried out by three speech therapists and two 
otorhinolaryngologists, followed by the classification in 
each one of these scales, with the agreement of at least 
four evaluators.
Voice capture
Voice was captured directly to the computer by 
means of the Windows® sound recorder, with the micro-
phone positioned laterally and at 5 cm from the individual’s 
mouth16. Each participant was submitted to uttering the 
vowel /a/, modal, without time control, in the following si-
tuations: without auditory masking, with auditory masking 
by broadband noise - “white noise”, binaural, simultaneous 
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at 40, 70 and 90 decibels sensation level (dBSL)17.
Acoustic analysis
The data set  collected was submitted to acoustic 
analysis by the voxmetria® software, in which we analyzed 
intensity variation in dB and the fundamental frequency in 
Hz of vocal utterance, before and after auditory masking, 
indirectly assessed by standard deviation within each 
utterance.
Statistical Analysis of the Data
For each parameter analyzed, we assessed the follo-
wing factors: auditory masking intensity interference, the 
behavior of the Control and the Parkinson’s Groups, the 
behavior of males and females, the difference between 
the control and Parkinson’s groups, differences between 
males and females, and the behavior of gender and group 
factors when assessed simultaneously.
The comparisons made between Parkinson and con-
trol were expressed as average and statistically analyzed 
by Repetitive Measures Variance Analysis. 
In all the tests, we used a significance level of 5% 
(p 0.05).
RESULTS
Intensity
Tables 1 and 2 show that vocal utterance intensity 
varies according to masking intensity (p<0.001), tending 
towards a non-linear increase (p<0.001). This increase 
is not influenced by Group (p=0.066) and nor by gen-
der (p=0.683). There is no behavior difference between 
genders (p=0.240) nor between groups (p=0.430). When 
we compared both groups and genders simultaneously, 
behavior is similar (p=0.826). Such results show that, 
regardless of the group studied and gender, the trend is 
always of intensity increase. The graph represented in 
Figures 1, 2 and 3 show vocal utterance intensity behavior 
in the control and Parkinson’s Groups, as well as male 
and female genders. 
Table 1. Utterance intensity average in dB, according to the auditory 
masking, by group and gender. 
M
as
ki
ng
Utterance intensities mean values (dB)
Control Group Parkinson’s Group
Male Female Total Male Female Total
0dB 76,7 74,5 75,6 74,3 72,2 73,2
40dB 79,0 75,0 77,1 77,0 72,8 74,9
70dB 82,8 80,3 81,6 82,1 78,4 80,3
90dB 86,2 85,1 85,7 87,5 83,7 85,6
Table 2. Vocal utterance intensity repetitive measures variance 
analysis.
Factor p value
Masking intensity < 0.001
Group interaction 0.066
Gender interaction 0.683
Group differences 0.430
Gender differences 0.240
Group x gender interaction 0.826
Figure 1. Vocal utterance intensity (dB), according to auditory masking 
intensity in the Control and Parkinson’s Groups.
Figure 2. Vocal utterance intensity (dB), according to auditory masking 
intensity in the Control Group, males and females.
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Intensity stability within each vocal utterance
This parameter was indirectly assessed through the 
intensity standard deviation within each vocal utterance.
Tables 3 and 4 show that the intensity standard 
deviation within each vocal utterance varies according to 
masking intensity (p<0.001), tending towards a non-linear 
reduction (p<0.001). This reduction is not influenced by 
group (p=0.557), nor by gender (p=0.807). There is no 
behavior difference between the genders (p=0.180) nor 
between the groups (p=0.776). When compared both 
groups and genders simultaneously, behavior was similar 
(p=0.460). Thus, the results show a trend towards stability, 
with a more uniform vocal utterance as far as intensity 
is concerned. The graphs shown on Figures 4, 5 and 6 
present the intensity standard deviation behavior in each 
utterance in the Control and Parkinson’s Groups, as well 
as in males and females. 
Table 3. Mean values of the intensity standard deviations within each 
vocal utterance in dB, according to auditory masking by group and 
gender.
M
as
ki
ng
Utterance intensities standard deviation mean values 
(dB)
Control Group Parkinson’s Group
Male Female Total Male Female Total
0dB 2,4 1,9 2,1 2,6 2,3 2,5
40dB 2,7 2,0 2,4 2,2 2,4 2,3
70dB 1,9 1,8 1,9 2,2 1,8 2,0
90dB 1,9 1,8 1,9 1,8 1,8 1,8
Table 4. Repetitive measures variance analysis for the intensity stan-
dard deviation within each vocal utterance.
Factor p Value
Masking intensity < 0.001
Group interaction 0.557
Gender interaction 0.807
Group differences 0.776
Gender differences 0.180
Group x gender interaction 0.460
Figure 3. Vocal utterance intensity (dB), according to auditory masking 
intensity in the Parkinson’s Group, males and females.
Figure 4. Vocal utterance intensity standard deviation (dB), according 
to auditory masking intensity, Control and Parkinson’s Group.
Figure 5. Vocal utterance intensity standard deviation (dB), according 
to auditory masking intensity, Control group, males and females.
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 Vocal utterance frequency
Tables 5 and 6 show that vocal utterance frequency 
varies according to masking intensity (p<0.001), tending 
towards non-linear increase (p<0.001). This increase is not 
influenced by group (p=0.747) nor by gender (p=0.640). 
There is a behavior difference between genders (p<0.001), 
and it was higher for females. Repetitive measures variance 
analysis suggests a difference between groups (p=0.056), 
which was higher in the Parkinson’s group. When we 
compared both groups and gender simultaneously, the 
behavior was similar (p=0.201). This result means that, 
in both groups and genders there is an increase in vocal 
utterance frequency during exposure to auditory masking. 
The behavior in both the Control and Parkinson’s groups, 
as well as in males and females can be seen in the charts 
shown in Figures 7, 8 and 9.
Figure 6. Vocal utterance intensity standard deviation (dB), according 
to auditory masking intensity, Parkinson’s Group males and females.
Table 5. Utterance frequencies average in Hz, according to auditory 
masking, by group and gender.
M
as
ki
ng
Utterance frequencies average (Hz)
Control Group Parkinson’s Group
Male Female Total Male Female Total
0dB 126,6 174,1 150,4 138,7 210,2 172,4
40dB 130,1 179,6 154,9 138,6 211,4 172,9
70dB 137,9 185,5 161,7 144,6 219,1 179,6
90dB 156,3 193,8 175,1 158,4 233,6 193,8
Table 6. Variance analysis of the repeated vocal utterance fre-
quency.
Factor p Value
Masking intensity < 0.001
Group interaction 0.747
Gender interaction 0.640
Group differences 0.056
Gender differences < 0.001
Group x gender interaction 0.201
Figure 7. Vocal utterance frequency (Hz), according to auditory 
masking intensity, Control and Parkinson’s groups.
Figure 8. Vocal utterance frequency (Hz), according to auditory 
masking intensity, Control group, males and females.
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Frequency stability within a given vocal utterance
This parameter was assessed indirectly through 
the frequency standard deviation within each vocal ut-
terance. 
Tables 7 and 8 show that the frequency standard 
deviation within each vocal utterance varies according to 
masking intensity (p<0.001), tending towards non-linear 
reduction (p<0.001). This reduction occurs differently in 
the different groups (p=0.012) and genders (p=0.002). This 
behavior difference does not allow testing the differences 
between the Control and the Parkinson’s Group and betwe-
en males and females. It is possible to suggest that there 
is a trend towards vocal utterance frequency stability. The 
graphs presented in Figures 10, 11 and 12 show different 
behavior between the Control and Parkinson’s groups, as 
it happens between males and females in both groups.
Figure 9. Vocal utterance frequency (Hz), according to auditory 
masking intensity, Parkinson’s group, males and females.
Table 7. Average value of frequency standard deviation within each 
vocal utterance in Hz, according to auditory masking, by group and 
gender. 
M
as
ki
ng
Mean values of the standard deviation in the utterance 
frequencies (Hz)
Control Group Parkinson’s Group
Male Female Total Male Female Total
0dB 2,7 3,7 3,2 3,7 8,8 6,1
40dB 2,5 3,5 3,0 3,2 7,5 5,2
70dB 2,6 3,6 3,1 3,0 4,8 3,9
90dB 2,6 3,1 2,8 3,7 4,1 3,9
Table 8. Variance analysis of the frequency standard deviation mea-
sures within each vocal utterance.
Factor p Value
Masking intensity <0.001
Group interaction 0.012
Gender interaction 0.002
Group difference 0.003
Gender difference 0.002
Group x gender difference 0.086
Figure 10. Vocal utterance frequency standard deviation (Hz), accor-
ding to auditory masking intensity, Control and Parkinson’s groups.
Figure 11. Vocal utterance frequency standard deviation (Hz), ac-
cording to auditory masking intensity, Control group, males and 
females.
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DISCUSSION
Voice neural control involves integration between 
the somatic motor system and the limbic system, invol-
ving fibers that go from the cortex, passing through the 
basal nuclei and by the mesencephalic substantia nigra18. 
The basal nucleus plays an important role in modulating 
cortical impulses19. Such modulation is reduced in PD, 
because of degeneration in the substantia nigra present at 
the base of the mesencephalus, involving not only dopa-
minergic neurons, but also other structures that produce 
serotonin, noradrenalin and acetylcholine in the genesis of 
the disease. The affected zone influences extra-pyramidal 
motor control, in other words, they control autonomous 
movements such as facial muscles (unconscious emotional 
communication), for example. Moreover, these neurons 
modify basic conscious commands coming from motor 
cortical neurons in a way to execute movements smoothly 
and without losing balance. It is also this extrapyramidal 
system that prevents continuous contraction or relaxation, 
and these events directly affect voice production20,21.
Thus, voice and speech difference, known as dy-
sarthrophonia, represent an important set of signs and 
symptoms in PD. Traditional methods of phonotherapeu-
tic treatment were not efficient to treat these alterations6. 
Currently, LSVT® has been the most used technique, and 
the one showing the best results6,21. Some authors have 
proposed some alternatives to improve these patients11,12,22, 
however, the only statistically proven method is LSVT® 
21.
This limited number of alternatives was the major 
driver for this study, and besides, the method proposed 
is simple to use and it can be improved in the future to 
be used in screening patients for treatment, indicating, for 
instance, those patients with better prognoses. 
Discussion of the results
In order to facilitate results discussion, each para-
meter was analyzed separately.
Vocal utterance intensity
Utterance intensity increased in both groups eva-
luated and in both genders, matching results found in 
the literature9,11,23,24,25. This increase was progressive and 
proportional to the increase in masking that is offered, 
that is, the greater the masking, the greater will be vocal 
utterance intensity, in agreement with studies previously 
published (Figure 1, Figure 2, Figure 3)9,11,12,26-30.
However, the initial average intensity of auditory 
pre-masking utterance was reduced in the group with 
Parkinson’s when compared to the Control group (Figure 
1), confirming hypophonia as an important characteristic 
in these individuals3,5,6,11,12,31.
All the individuals in the Parkinson’s group used 
levodopa or dopaminergic agonists as a pharmacologic 
measure. There is no consensus in the literature as to voice 
improvements with the use of levodopa and dopaminergic 
agonists. Some papers suggest that pharmacologic treat-
ment does not bring about significant improvements in 
vocal traits31,32. Others suggest that speech improvements 
due to medication use occur mainly with the symptoms 
related with joint and posture, considered dopamine-
dependents, and were not very much felt in parameters 
such as tremor5,33. There are those that advocate that drug 
treatment promotes significant speech improvements34,35. 
In our study, although there has been an increase in voice 
intensity, both in auditory perception and through acous-
tic analysis, utterance intensity in the Parkinson’s group 
was less, suggesting that the “pharmacological treatment” 
factor, although bringing some voice improvement, is not 
enough to normalize patterns. 
Results suggest that, as it happens with vocal thera-
py, the goal in voice intensity increase is reached through 
LE6,11,12,21,22,36.
Vocal Utterance Intensity Instability 
This parameter was indirectly checked by means of 
a standard deviation pattern within each vocal utterance. 
It tended towards reduction in both groups, varying pro-
portionally in relation to masking intensity. That is, the 
more intense the masking, the lower is the vocal utteran-
ce standard deviation. There was no behavior difference 
between Parkinson’s and the Control group. It is possible 
to visually perceive these findings (Figure 4).
Such findings suggest that an increase in vocal ut-
terance intensity improves stability in terms of intensity, 
and this improvement was similar in both groups. This is 
an important finding in patients with PD, since one of the 
characteristics of this group is the difficulty in maintaining 
vocal utterance stability during speech4,5.
There are no papers in the literature describing the 
use of this analysis parameter. Thus, the comments hereby 
Figure 12. Vocal utterance frequency standard deviation (Hz), ac-
cording to auditory masking intensity, Parkinson’s group, males and 
females.
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made were based on acoustic and perception analysis 
findings, and on statistical analysis of the data. 
Vocal Utterance Frequency
Utterance frequency increased in both groups as-
sessed and in both genders. This increase was progressive 
and proportional to the increase in masking used, that is, 
the higher the masking, the greater the vocal utterance 
intensity reflecting in a higher fundamental frequency and 
a greater vocal utterance power37. Average utterance fre-
quency was greater in females, which did not confirm the 
findings from Holmes et al. (2000)5, who found a reduction 
in the fundamental frequency in women and an increase 
in men. Perception and auditory findings match the results 
from the acoustic analysis, also in disagreement from the 
findings by Holmes et al. (2000)5. A hypothesis that could 
explain this disagreement is the fact that patients in this 
study were in the initial stages of the disease, while those 
from the study aforementioned belonged to many stages 
of the disease. 
As to the fundamental frequency in these patients, 
literature is scarce, showing that their major interest is 
utterance intensity, followed by the alterations that mark 
the instability. In this sense, it is important to assess vocal 
utterance frequency in PD patients. 
Vocal Utterance Frequency Stability
Just as it happened with vocal utterance intensity 
stability, this parameter was indirectly assessed by means 
of the fundamental frequency standard deviation within 
each vocal utterance. In both groups, this parameter tended 
to reduce, varying proportionally in relation to masking 
intensity. That is, the more intense the masking, the lower 
is vocal utterance frequency standard deviation. However, 
the behavior difference did not let us test differences be-
tween the Control and the Parkinson’s Groups as far as 
gender is concerned. It is possible to suggest that there is 
a trend towards vocal utterance frequency stability. 
The comments made hereby were based on evalu-
ating the Graph (Figure 10) that represent the analysis of 
the parameter tested, assessing the behavior of both, the 
Control and the Parkinson’s Groups.
The Graph (Figure 10) shows that the control group 
curve tends to be flatter, suggesting greater frequency sta-
bility in vocal utterance in this group. In the Parkinson’s 
group, values start high and tend to stabilize after masking 
with 70dBSL. This stability is important for total voice 
improvement in these patients4,5.
Literature has no paper describing the use of such 
analysis parameter. The comments hereby made were 
based on the findings of acoustic analyses, perception and 
auditory analysis, and data statistical analysis. 
FINAL REMARKS
If we consider that speech mirrors our personalities, 
which is unique in its vibrations, tones and musicality, it 
becomes easier to understand how much these changes 
interfere in the daily activities of these patients and in their 
social relations. However, the means specifically created 
for language improvement in these patients are still limited, 
currently being restricted to LSVT®. Surgical treatment is 
still far from us. The “Deep Brain Stimulation”, whose goal 
is to reduce the activities of the globus pallidus, subtha-
lamic nucleus and thalamus, is a great promise for these 
patients38. Postoperative results have been very promising 
with important voice improvements, showing the way to 
a new therapeutic horizon39-42. However, we have to take 
into account that this technology is not available to most 
of these patients, especially in a developing country like 
Brazil, thus the importance of developing innovative and 
accessible approaches that help in assessing and treating 
vocal symptoms in this group. Studies such as those from 
Adams, Lang (1992)11, and Angelis et al. (1997)22 and Ho et 
al. (1999)12 are highly important because, besides opening 
new therapeutic horizons, have fostered new studies in 
search of a better quality of life for this group. 
CONCLUSION
The Lombard effect causes significant increase in 
vocal utterance fundamental frequency for individuals with 
Parkinson’s disease. Results also suggest an improvement 
in vocal utterance stability, both in terms of intensity and 
fundamental frequency. When we compare the results 
between the Control and the Parkinson’s Group, both 
present similar behavior, suggesting that the LE occur in 
both groups apparently in the same way. 
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